CPQ Cancer

[cancer@cientperiodique.online]                                                                                            Special Submissions to COVID Issue

Category: Gold Open Access                           Indexing Sites: Google Scholar, Click to view PublonsClick to view                     Current Issue: Volume 3 Issue 1
  Frequency: Bimonthly                                     Article Submission: 03 May 2021                                  Upcoming Release: 14 May 2021
Honourable Reviewers of Current Articles: Dr. Emeka Taye Umezurike, Dr. Tarek Mohamed Kamal Motawi, Dr. Erisa Kola, Dr. Sicong Zhang, Dr. Giulio Tarro & Dr. Chrow Khurshid

Cancers are often managed through technological advancements with the help of multi-disciplinary cancer conferences where medical oncologists, surgical oncologists, radiation oncologists, pathologists, radiologists and organ specific oncologists meet to find the best possible management for an individual patient considering the physical, social, psychological, emotional and financial status of the patient. Valuable, important updates on behalf of oncologists with respect to the latest advancements in oncology, enables the management of cancer. Clinical trials in respective aspects are very essential for all the patients in whom cancer progresses and for whom no standard of care treatment options are available. In certain circumstances, an oncologist can mean the difference between life and death.

Cancer research enables to identify the causes and to develop strategies for prevention, diagnosis, treatment, and also to improve the performance of clinical trials to evaluate and compare the applications of various cancer treatments.

Journal Features

    • Immediate response towards the articles received.
    • Accepts papers from all areas of Cancer.
    • Providing rapid update regarding articles.
    • Presence of pertinent Editors and Reviewers.
    • Prompt peer review and decisions upon papers.
    • Comprehensive review through Editors and Reviewers with proficiency in the associated field.
    • Comfortable online and e-mail submission.
    • Fair decision making and ethics to ensure every decision is fair and transparent.
    • Grant of publication certificate to the authors.
    • “Best Article of Issue” certificate after each issue release.

Aim and Scope

Subject areas include, but are not restricted to the following fields:

Anticancer Agents, Apoptosis, Biomarkers & Treatment, Cancer Biology, Cancer Informatics, Cancer related Ethics, Cancer Toxicology, Carcinogenesis, Cell, Molecular & Stem Cell Biology, Cellular Oncology, Diagnostics, Drug Discovery & Delivery, Epidemiology & Prevention, Epidemiology and Cancer Prevention, Genetics and Epigenetics, Genetics, Genomics & Proteomics, Immunotherapy, Inflammation & Virology, Kaposi Sarcoma, Leukaemia, Metabolism, Molecular Cancer, Mutagenesis, Myeloma Cells, Oncogenes, Pathology, Predictive Markers, Radiation Oncology, Resistance and Metastasis, Tumour Microenvironment, Tumour Necrosis.

The desire of CPQ Cancer is to publish articles in all related aspects.

Latest Articles

Visualization of an Intra-Operative X-Ray Source With Liquid Scintillation Imaging

Peter A. Sandwall

Intraoperative radiotherapy (IORT) is an alternative to full course radiotherapy for select patients. The IntraBeam (Zeiss, Germany) delivery system uses a low energy (50kVp) x-ray source. In this communication, a method for rapidly characterizing emissions from an IORT x-ray source is shared. A leaded glass phantom was filled with liquid scintillation cocktail (LSC) (Ultima Gold; PerkinElmer, USA) and a 13 MP CMOS detector used to collect images and videos. [...] READ MORE

View Full Text | Download PDF

COVID-19 and the Severity of the Disease in Different Types of Cancer

Eben von Well

Italy, Spain and the USA suffered the most in the early stages of the world wide outbreak of COVID-19 and subsequently the World Health Organization (WHO) declared the COVID-19 outbreak a global pandemic on 12 March 2020. Cancer patients with comorbidities (hypertension, diabetes and cardiorenovascular diseases) can lead to severe illness and death as cancer patients have a higher risk of severe illness and death than COVID-19 patients without cancer. [...] READ MORE

View Full Text | Download PDF

COVID-19 and Cancer Review: Surgical Oncology, Telemedicine, and Mental Health

Shon Shmushkevich1,2#, Massimo Baudo3#, Mahmoud Morsi4, Mariam Khobsa5, Mohamed Ismael6, Ayah Hassan, A.7, Mostafa Rahouma8 & Mohamed Rahouma9*#

Due to the spread of COVID-19, many medical institutions began to cancel/postpone elective procedures out of concerns for safety. The American College of Surgeons (ACS) and the Centers for Disease Control and Prevention (CDC) recommended cancelling or postponing non-emergent surgeries since March 2020 [1]. [...] READ MORE

View Full Text | Download PDF

When Ribosomal Protein Go Bad-Mutation of Ribosomal Protein RPS23 in Different Diseases

Shefki Xharra1#, Emir Behluli2#, Hilada Nefic3, Rifat Hadziselimovic3, Kumrije Sopi-Xharra1 & Gazmend Temaj4#*

Ribosomal protein (RP) gene mutations, mostly are associated with inherited or acquired bone marrow failure; it is believed that RP to drive disease by slowing the rate of protein synthesis. Ribosomes, are responsible for protein synthesis; ribosome, consist of a small 40S subunit and a large 60S subunit. [...] READ MORE

View Full Text | Download PDF

Immunotherapy in Colorectal Cancer: A Promising Avenue?

Danielle Hebert BS#, Kayla Flewelling BS#, Najiha Farooqi MD & Mohamed Kamel, K. MD*

Advancements in immunotherapy, particularly immune checkpoint inhibitors, have revolutionized the treatment of metastatic colorectal cancer (mCRC). However, the efficacy of available immunotherapeutic agents is largely limited to tumors with DNA mismatch repair-deficient (dMMR) and/or those with microsatellite instability-high (MSI-H) mCRC. [...] READ MORE

View Full Text | Download PDF

Effect of the COVID-19 Pandemic on Cancer Treatment

Yanshan Ge1,2 & Minghua Wu1,3*

Since being identified as a public health emergency of major international concern, the outbreak of coronavirus disease (COVID-19) in 2019 has rapidly spread globally and has now been declared a pandemic by the World Health Organization (WHO). COVID- 19 has the characteristics of rapid spread from person to person. Many cancer patients often go to the hospital for treatment and disease monitoring. [...] READ MORE

View Full Text | Download PDF

The Impact of COVID-19 on Cancer Care and Research

Winston Wong, PharmD

No one predicted what the impact of COVID-19 upon globe would have been. The impact has been devastating, from a humanistic as well as from healthcare perspective. However, I am constantly reminded that no matter where the final numbers tally out to with respect to the human tragedy, COVID-19 thus far is not even close to the Great Flu Epidemic in 1917 during World War I. [...] READ MORE

View Full Text | Download PDF

A Novel Bioinformatic Approach for Large Deletion Detection in Multiplex Pcr-Based Ngs Assays

Fatemeh Abbaszadeh*, Shaza Abu Sirriya, Bincy Mathew, Ramin Badii, Vasiliki Chini, Zafar Nawaz & Susanna Akiki

Next-generation sequencing (NGS) has changed genetic diagnostics due to its high throughput, speed, and cost-effectiveness. This paper describes the challenges that were faced in detection of the frameshift variant c.1175_1214del in the BRCA1 gene, undetectable by CNV analysis, using Oncomine BRCA Research Assay (OBRA) and Ion Torrent platform. [...] READ MORE

View Full Text | Download PDF

Consequences of Blood Loss in Cardiothoracic Surgery

Massimo Baudo1*, Mohamed Rahouma2*, Mahmoud Morsi3, Yongle Ruan4, Sherif Khairallah2, Mohamed Kamel2, Galal Ghaly2, Ali Cheriat, N.5, Mohamed Hossny6, Omnia Mohamed7 & Abdelrahman Mohamed2

Efforts to minimize perioperative blood loss in surgery in order to improve short and long- term outcome should be made, as implications extend considerably beyond the perioperative period. Minimally invasive approaches are associated with less bleeding. [...] READ MORE

View Full Text | Download PDF

Evaluation of Clinical Manifestations and Their Effect on the Prognosis of Lung Cancer Patients

Halil Yanardag1, Cuneyt Tetikkurt2*, Cigdem Papila3, Muammer Bilir1 & Seza Tetikkurt4

Survival of lung cancer patients are affected by many different factors that are extremely variable for each individual. The prognosis of lung cancer primarily depends upon the tumor type, patient immunity and treatment. The objective of our study was to determine the influence of patient symptoms, laboratory findings, imaging modalities and histopathologic tumor features on the prognostic outcome of lung cancer patients. [...] READ MORE

View Full Text | Download PDF

Total Articles Published



Cient Periodique is a ‘Gold’ open access publisher that aspires to offer absolute free, unrestricted access to the valuable research information

We welcome all the eminent authors to submit your valuable paper

Cient Periodique invites the participation of honourable Editors and Authors

CPQ Journals provide Certificates for publication

Cient Periodique also offers memberships for potential Authors

Best Articles will be appreciated with the provision of corresponding Certificate